Merit Medical Systems, Inc. (MMSI)
| Market Cap | 4.18B |
| Revenue (ttm) | 1.15B |
| Net Income (ttm) | 74.52M |
| Shares Out | 57.32M |
| EPS (ttm) | 1.29 |
| PE Ratio | 56.14 |
| Forward PE | 25.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,723 |
| Open | 72.69 |
| Previous Close | 72.42 |
| Day's Range | 72.42 - 73.00 |
| 52-Week Range | 50.46 - 76.14 |
| Beta | 0.99 |
| Analysts | Buy |
| Price Target | 79.82 (+9.49%) |
| Earnings Date | Apr 26, 2023 |
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid man... [Read more]
Financial Performance
In 2022, MMSI's revenue was $1.15 billion, an increase of 7.09% compared to the previous year's $1.07 billion. Earnings were $74.52 million, an increase of 53.79%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is $79.82, which is an increase of 9.49% from the latest price.
News
Merit Medical's (MMSI) New Launch to Boost its Product Suite
Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly enhance patient outcomes.
Merit Medical Launches Expanded SwiftNINJA® Steerable Microcatheter Offering
New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products New sizes of advanced articulating microcatheter enhance a market-leading portfolio of v...
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
MMSI vs. WST: Which Stock Is the Better Value Option?
MMSI vs. WST: Which Stock Is the Better Value Option?
Merit Medical (MMSI) Q4 Earnings Top Estimates, Margins Down
Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in its Cardiovascular segment and the majority of product categories within its Cardiovascular unit.
Merit Medical (MMSI) Q4 Earnings and Revenues Surpass Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of 17.91% and 1.26%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2022 Issues Fiscal Year 2023 Guidance
* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-G...
Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance System
Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment Next-generation system helps improve surgical precision to enhance pati...
Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
SOUTH JORDAN, Utah, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...
5 Dental Supplies Stocks to Buy Amid Recovering Prospects
Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.
MMSI or ALGN: Which Is the Better Value Stock Right Now?
MMSI vs. ALGN: Which Stock Is the Better Value Option?
Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
Investors continue to be optimistic about Merit Medical (MMSI), owing to its strong product portfolio.
MMSI vs. ALGN: Which Stock Is the Better Value Option?
MMSI vs. ALGN: Which Stock Is the Better Value Option?
Merit Medical (MMSI) Hits 52-Week High: What's Driving It?
Investors are optimistic about Merit Medical's (MMSI) slew of product launches.
First Patient Enrolled in Merit Medical's Multicenter Observational Study to Evaluate the Use of EmboCube® Embolization Gelatin to Control Bleeding or Hemorrhage
SOUTH JORDAN, Utah, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the successful en...
Merit Medical (MMSI) Launches New Inflation Device basixALPHA
Merit Medical (MMSI) launches basixALPHA inflation device in the United States for one-handed preparation and fast inflation with minimal exertion to streamline angioplasty procedures.
Merit Medical Launches the basixALPHA™ Inflation Device
Ergonomic device provides fast inflation to streamline angioplasty procedures Ergonomic device provides fast inflation to streamline angioplasty procedures
Merit Medical's (MMSI) New Launch to Boost Patient Outcome
Merit Medical's (MMSI) latest addition to its radial portfolio is expected to significantly optimize hemostasis for radial artery procedures.
Fred Lampropoulos Receives Manufacturing Leader of the Year Award from the Utah Manufacturers Association
SOUTH JORDAN, Utah, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced that Fred Lampropoulos,...
Merit Medical Launches the PreludeSYNC EZ™ Radial Compression Device
Unique band provides precise placement and clear visibility of the access site, optimizing hemostasis for radial artery procedures Unique band provides precise placement and clear visibility of the ac...
MMSI vs. CNMD: Which Stock Should Value Investors Buy Now?
MMSI vs. CNMD: Which Stock Is the Better Value Option?
Summary Notice to Current Merit Medical Systems, Inc. Stockholders of Derivative Action and Settlement Hearing
SALT LAKE CITY, Nov. 02, 2022 (GLOBE NEWSWIRE) -- TO: ALL OWNERS OF MERIT MEDICAL SYSTEMS, INC. (“MERIT” OR THE “COMPANY”) COMMON STOCK AS OF AUGUST 17, 2022 (“CURRENT MERIT STOCKHOLDERS”)
Merit Medical Announces the Appointment of Joe Wright to Chief Commercial Officer
Merit's long-time executive, Joe Wright, has been appointed to the new role of Chief Commercial Officer and will be responsible for leading all commercial activities for the global organization. Merit...
Merit Medical (MMSI) Q3 Earnings Beat, FY22 View Revised
Merit Medical (MMSI), in the third quarter, benefits from revenue growth in both its segments and the majority of product categories within its Cardiovascular unit.
Merit Medical (MMSI) Q3 Earnings and Revenues Top Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of 20.75% and 5.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?